Exclusive special offer and discount title banner vector image

JAPAN COUGH SYRUP MARKET FORECAST 2023-2030

SCOPE OF THE REPORT

Japan Cough Syrup Market by Product Type (Cough Suppressants, Combination Medicines, Expectorants) Market by Age Group (Adults, Adolescents, Pediatric) Market by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-pharmacies)

REQUEST FREE SAMPLE

MARKET OVERVIEW

The Japan cough syrup market growth is anticipated to progress at a CAGR of 4.19% during the forecast period, 2023-2030, and is predicted to garner a revenue of $453.34 million by 2030.

Japan’s distinctive demographic landscape, characterized by having the world’s highest elderly population, with approximately 28% of its citizens aged 65 years or older, exerts a significant influence on the healthcare product market, particularly cough syrups. This demographic pattern is fueling the demand for cough syrup in Japan, in tandem with the government’s commitment to making healthcare affordable and accessible. The sizable elderly population in Japan is more prone to respiratory issues such as coughs and colds due to weakened immune systems and age-related health conditions.

Further, the Japanese government’s dedication to affordable healthcare plays a central role in stimulating the demand for cough syrups. Japan maintains a robust national healthcare policy that prioritizes the affordability and accessibility of healthcare products, including medications, for all of its citizens. The government actively regulates drug prices, promotes the use of generic medications, and engages in negotiations with pharmaceutical companies to manage healthcare expenses. This approach guarantees that cough syrups and other vital medicines remain accessible to both the elderly and the wider population.

Japan Cough Syrup Market

To Know More About This Report, Request a Free Sample Copy

The Japan cough syrup market segmentation includes age group, distribution channel, and product type. The product type segment includes expectorants, combination medicines, and cough suppressants.

Cough suppressants, also referred to as antitussives, are medications designed to reduce or eliminate coughing by targeting the cough reflex in the brain, thus diminishing the urge to cough. The increased demand for cough suppressants can be attributed to several factors, with the ongoing global health challenges, such as the COVID-19 pandemic, being a significant driver. Coughing is a prevalent symptom of respiratory infections, particularly COVID-19, which has heightened public awareness regarding the act of coughing and its potential for disease transmission. Consequently, individuals with mild coughs resulting from allergies, colds, or other causes are more inclined to seek out cough suppressants as a means of managing their symptoms and reducing the perceived risk of spreading illness.

The widespread availability of cough suppressants as over-the-counter (OTC) medications has played a pivotal role in fueling the high demand for these products. Given that OTC drugs are easily accessible to consumers without the need for a prescription, they are commonly used as part of self-medication practices. This convenience has contributed to the extensive utilization and subsequent surge in demand for cough suppressants.

Furthermore, expectorants are medications designed to facilitate the loosening and thinning of mucus within the respiratory passages, simplifying the process of coughing it up and clearing it from the respiratory system. These pharmaceuticals are commonly found in cough syrups and are frequently recommended for individuals with productive coughs who aim to expel excess mucus from their lungs and airways.

Moreover, alterations in environmental conditions, air quality, and exposure to allergens can contribute to respiratory problems and coughing. As individuals encounter these factors more frequently, they may develop coughs accompanied by increased mucus production. Consequently, there is an escalating demand for expectorant cough syrups that aid in the elimination of mucus and alleviate the associated discomfort.

Some of the key firms operating in the Japan cough syrup market are GSK plc, Procter & Gamble, Reckitt Benckiser Group PLC, etc.

GSK plc is a healthcare company that focuses on manufacturing, commercializing, and developing vaccines, specialty medicines, and general medicines. It offers drugs for treating central nervous system (CNS) disorders, HIV, anti-viral diseases, rare diseases, cancer, cardiovascular diseases, etc. Also, it offers over-the-counter (OTC) products for gastrointestinal diseases, skin health, nutrition, oral health, and pain relief. It sells its products through physicians, hospitals, pharmacies, and wholesalers. The company is headquartered in Brentford, Middlesex, the United Kingdom.

Its product portfolio includes a vast range of products that offer symptomatic relief from cough, rhinitis, and nasal congestion.

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2028
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Segments Analyzed
Product Type, Age Group, Distribution Channel
Countries AnalyzedJapan
Companies AnalyzedGSK plc, Novartis AG, Pfizer Inc, Procter & Gamble, Reckitt Benckiser Group PLC

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. METHODOLOGY
    3. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS
    4. SCOPE OF STUDY
    5. CRISIS SCENARIO ANALYSIS
      1. IMPACT OF COVID-19 ON COUGH SYRUP MARKET
      2. IMPACT OF THE RUSSIA-UKRAINE WAR ON COUGH SYRUP MARKET
    6. MAJOR MARKET FINDINGS
      1. PRODUCT DIVERSIFICATION IS ON THE RISE
      2. DOMINANCE OF OTC COUGH SYRUPS HAS DRIVEN ACCESSIBILITY
      3. HEALTHCARE INFORMATION AVAILABILITY ON DIGITAL PLATFORMS INFLUENCES CONSUMER CHOICES
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. PREVALENCE OF RESPIRATORY AILMENTS
      2. RISING GERIATRIC POPULATION
      3. INNOVATIONS IN COUGH SYRUPS
    2. KEY RESTRAINTS
      1. OVER-DOSAGE CONCERNS DRIVING CONSUMERS TOWARD ALTERNATIVES
      2. STRINGENT REGULATORY PROTOCOLS
      3. INCREASING CASES OF COUGH SYRUP DEATHS
  4. KEY ANALYTICS
    1. KEY MARKET TRENDS
      1. INCREASING SELF-MEDICATION TRENDS
      2. SHIFTING CONSUMER PREFERENCE TOWARD HERBAL COUGH SYRUPS
      3. RISING POPULARITY OF E-COMMERCE CHANNELS
      4. COMPANIES ARE OFFERING SUGAR-FREE COUGH SYRUPS
      5. GROWING INCLINATION TOWARD HOMEOPATHIC COUGH SYRUPS
    2. PEST ANALYSIS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. GROWTH PROSPECT MAPPING
      1. GROWTH PROSPECT MAPPING FOR JAPAN
    5. VALUE CHAIN ANALYSIS
  5. MARKET BY PRODUCT TYPE
    1. COUGH SUPPRESSANTS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. COMBINATION MEDICINES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. EXPECTORANTS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  6. MARKET BY AGE GROUP
    1. ADULTS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. ADOLESCENTS
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. PEDIATRIC
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  7. MARKET BY DISTRIBUTION CHANNEL
    1. RETAIL PHARMACIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    2. HOSPITAL PHARMACIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
    3. E-PHARMACIES
      1. MARKET FORECAST FIGURE
      2. SEGMENT ANALYSIS
  8. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS & AGREEMENTS
      4. BUSINESS EXPANSIONS & DIVESTITURES
    2. COMPANY PROFILES
      1. GSK PLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      2. NOVARTIS AG
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      3. PFIZER INC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      4. PROCTER & GAMBLE
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES
      5. RECKITT BENCKISER GROUP PLC
        1. COMPANY OVERVIEW
        2. PRODUCT LIST
        3. STRENGTHS & CHALLENGES

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – COUGH SYRUP MARKET

TABLE 2: JAPAN COUGH SYRUP MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: JAPAN COUGH SYRUP MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2023-2030 (IN $ MILLION)

TABLE 4: JAPAN COUGH SYRUP MARKET, BY AGE GROUP, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: JAPAN COUGH SYRUP MARKET, BY AGE GROUP, FORECAST YEARS, 2023-2030 (IN $ MILLION)

TABLE 6: JAPAN COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: JAPAN COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2030 (IN $ MILLION)

TABLE 8: JAPAN COUGH SYRUP MARKET REGULATORY FRAMEWORK

TABLE 9: KEY PLAYERS OPERATING IN JAPAN COUGH SYRUP MARKET

TABLE 10: LIST OF MERGERS & ACQUISITIONS

TABLE 11: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 12: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 13: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: GROWTH PROSPECT MAPPING FOR JAPAN

FIGURE 4: VALUE CHAIN ANALYSIS

FIGURE 5: JAPAN COUGH SYRUP MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2022

FIGURE 6: JAPAN COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2030 (IN $ MILLION)

FIGURE 7: JAPAN COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2030 (IN $ MILLION)

FIGURE 8: JAPAN COUGH SYRUP MARKET, BY EXPECTORANTS, 2023-2030 (IN $ MILLION)

FIGURE 9: JAPAN COUGH SYRUP MARKET, GROWTH POTENTIAL, BY AGE GROUP, IN 2022

FIGURE 10: JAPAN COUGH SYRUP MARKET, BY ADULTS, 2023-2030 (IN $ MILLION)

FIGURE 11: JAPAN COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2030 (IN $ MILLION)

FIGURE 12: JAPAN COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2030 (IN $ MILLION)

FIGURE 13: JAPAN COUGH SYRUP MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2022

FIGURE 14: JAPAN COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 15: JAPAN COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2030 (IN $ MILLION)

FIGURE 16: JAPAN COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2030 (IN $ MILLION)

FAQ’s

Request Customization
Request Customization